Waskow Research Group

Selected Publications

  • SETD1A protects HSCs from activation-induced functional decline in vivo.
    Arndt K, Kranz A, Fohgrub J, Jolly A, Bledau AS, Di Virgilio M, Lesche M, Dahl A, Höfer T, Stewart AF, Waskow C
    Blood 2018, 131(12), 1311-24
  • Niche WNT5A regulates the actin cytoskeleton during regeneration of hematopoietic stem cells.
    Schreck C, Istvánffy R, Ziegenhain C, Sippenauer T, Ruf F, Henkel L, Gärtner F, Vieth B, Florian MC, Mende N, Taubenberger A, Prendergast Á, Wagner A, Pagel C, Grziwok S, Götze KS, Guck J, Dean DC, Massberg S, Essers M, Waskow C, Geiger H, Schiemann M, Peschel C, Enard W, Oostendorp RAJ
    J Exp Med 2017, 214(1), 165-81
  • Improved Human Erythropoiesis and Platelet Formation in Humanized NSGW41 Mice.
    Rahmig S, Kronstein-Wiedemann R, Fohgrub J, Kronstein N, Nevmerzhitskaya A, Bornhäuser M, Gassmann M, Platz A, Ordemann R, Tonn T, Waskow C
    Stem Cell Reports 2016, 7(4), 591-601
  • The bulk of the hematopoietic stem cell population is dispensable for murine steady-state and stress hematopoiesis.
    Schoedel KB, Morcos MNF, Zerjatke T, Roeder I, Grinenko T, Voehringer D, Göthert JR, Waskow C, Roers A, Gerbaulet A
    Blood 2016, 128(19), 2285-96
  • Space constraints govern fate of hematopoietic stem and progenitor cells in vitro.
    Müller E, Grinenko T, Pompe T, Waskow C, Werner C
    Biomaterials 2015, 53, 709-15
  • CCND1-CDK4-mediated cell cycle progression provides a competitive advantage for human hematopoietic stem cells in vivo.
    Mende N, Kuchen EE, Lesche M, Grinenko T, Kokkaliaris KD, Hanenberg H, Lindemann D, Dahl A, Platz A, Höfer T, Calegari F, Waskow C
    J Exp Med 2015, 212(8), 1171-83
  • Kit regulates HSC engraftment across the human-mouse species barrier.
    Cosgun KN, Rahmig S, Mende N, Reinke S, Hauber I, Schäfer C, Petzold A, Weisbach H, Heidkamp G, Purbojo A, Cesnjevar R, Platz A, Bornhäuser M, Schmitz M, Dudziak D, Hauber J, Kirberg J, Waskow C
    Cell Stem Cell 2014, 15(2), 227-38
  • Clonal expansion capacity defines two consecutive developmental stages of long-term hematopoietic stem cells.
    Grinenko T, Arndt K, Portz M, Mende N, Günther M, Cosgun KN, Alexopoulou D, Lakshmanaperumal N, Henry I, Dahl A, Waskow C
    J Exp Med 2014, 211(2), 209-15
  • Tightly anchored tissue-mimetic matrices as instructive stem cell microenvironments.
    Prewitz MC, Seib FP, von Bonin M, Friedrichs J, Stißel A, Niehage C, Müller K, Anastassiadis K, Waskow C, Hoflack B, Bornhäuser M, Werner C
    Nat Methods 2013, 10(8), 788-94
  • CD133 is a modifier of hematopoietic progenitor frequencies but is dispensable for the maintenance of mouse hematopoietic stem cells.
    Arndt K, Grinenko T, Mende N, Reichert D, Portz M, Ripich T, Carmeliet P, Corbeil D, Waskow C
    Proc Natl Acad Sci U S A 2013, 110(14), 5582-7

Publications at FLI

2018

  • SETD1A protects HSCs from activation-induced functional decline in vivo.
    Arndt K, Kranz A, Fohgrub J, Jolly A, Bledau AS, Di Virgilio M, Lesche M, Dahl A, Höfer T, Stewart AF, Waskow C
    Blood 2018, 131(12), 1311-24